The potential use of bacteria and bacterial derivatives as drug delivery systems for viral infection
Year: 2023
Type: review
Abstract: Viral infections in humans are responsible for fatalities worldwide and contribute to the incidence of various human ailments. Controllable targeted medicine delivery against many illnesses, including viral infection, may be significantly aided by using bacteria and bacteria-derived products. They may accumulate in diseased tissues despite physical obstacles, where they can launch antiviral immunity. The ability to genetically and chemically modify them means that vaccinations against viral infections may be manufactured and delivered to affected tissues more safely and effectively. The objective of this study is to provide an overview of the latest advancements in the field of utilizing bacteria and bacterial derivatives as carriers for administering medication to treat viral diseases such as SARS-CoV-2, hepatitis B virus, hepatitis C virus, human immunodeficiency virus, human papillomavirus, influenza, and Ebola virus.
Source: Virology Journal
Institutions: Iran University of Medical Sciences, Al Noor University College, National University of Science and Technology, Al-Farahidi University, University of North Carolina at Greensboro, Al-Zahrawi University, Islamic Azad University of Tabriz, Tehran University of Medical Sciences, Shahid Beheshti University, Shahid Beheshti University of Medical Sciences
Language: English
Topic: Bacterial Cancer Therapy
Subfield: Biotechnology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,090
OpenAlex ID: W4387311595